EVP AND CFO · ABBOTT LABORATORIES · Common shares without par value
Side
BUY
Value
$201K
Shares
2,200
Price
$91.5
Executed
Apr 23, 2026
Disclosed
Apr 27, 2026
Disclosure timeline4 days from execution to publication · legal deadline 2 business days
Apr 23 executedApr 27, 2026 disclosed
ABT · daily
Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Boudreau Philip P filed this Form 4 reporting a open-market purchase of ABT on Apr 23, 2026. It became public on Apr 27, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
EVP AND CFO
Boudreau Philip Pcik:0001805099
Issuer
ABBOTT LABORATORIEScik:0000001800
Revision history · 0
No field has changed since this record was first ingested.
